NTRA – natera, inc. (US:NASDAQ)
Stock Stats
News
New Signatera™ Data in Lymphoma and Multiple Myeloma to be Presented at the 2025 American Society of Hematology Annual Meeting
Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San Antonio Breast Cancer Symposium
Natera (NASDAQ:NTRA) was given a new $265.00 price target on by analysts at Morgan Stanley.
Natera (NASDAQ:NTRA) had its price target raised by analysts at JPMorgan Chase & Co. from $240.00 to $250.00. They now have an "overweight" rating on the stock.
Employees Volunteer Over 1,500 Hours During Natera’s Annual Volunteer Month
Form 4 Natera, Inc. For: Dec 01 Filed by: Chapman Steven Leonard
Form 4 Natera, Inc. For: Dec 01 Filed by: Moshkevich Solomon
Form 144 Natera, Inc. Filed by: Chapman Steven Leonard
Form 144 Natera, Inc. Filed by: Moshkevich Solomon
Form 4 Natera, Inc. For: Nov 24 Filed by: BOTHA ROELOF
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.